Improving access to care for people who inject drugs

Qualitative evaluation of project ITTREAT—An integrated community hepatitis C service

Claire Phillips, Jasmine Schulkind, Margaret O'Sullvan, Natalie Edelman, Helen Smith, Sumita Verma, Christina Jones

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Achieving hepatitis C virus (HCV) elimination by 2030 requires an increased linkage to care for people who inject drugs (PWID). Project ITTREAT was established to mitigate barriers to HCV care by providing an integrated service within a local drug and alcohol treatment centre. This study aimed to explore the experiences of clients and staff involved in Project ITTREAT and assess the facilitators and barriers to a community‐based HCV service. Between October 2014 and April 2016, drug and alcohol treatment attendees were interviewed using one‐to‐one semi‐structured interviews. Drug and alcohol treatment staff took part in focus groups. All data were recorded, transcribed verbatim and analysed using thematic content analysis. Fifteen drug and alcohol treatment attendees with current/previous HCV infection were interviewed, and 15 staff members contributed across two focus groups. Drug and alcohol treatment staff and attendees reported that Project ITTREAT facilitated access to HCV care by mitigating previous negative hospital‐based experiences. Other key facilitators were positive narratives around HCV care, and drug and alcohol treatment attendees being well engaged in their drug/alcohol recovery. Barriers included a lack of stability in drug and alcohol treatment attendees, negative discourse around testing/ treatment and stigma associated with attending the drug and alcohol treatment to access HCV treatment in some who had successfully achieved drug rehabilitation. Our findings indicate the positive impact of an integrated and personalized community‐based service delivered by a dedicated hepatitis nurse. This played a crucial role in reducing barriers to HCV care for PWID. Our work also highlights areas for future investment including non–DAT‐based community services and increasing awareness of new treatments amongst this cohort.
Original languageEnglish
JournalJournal of Viral Hepatitis
DOIs
Publication statusPublished - 30 Sep 2019

Fingerprint

Drug Evaluation
Hepatitis C
Hepacivirus
Alcohols
Pharmaceutical Preparations
Therapeutics
Focus Groups
Substance Abuse Treatment Centers
Drug Stability
Social Welfare
Virus Diseases
Hepatitis
Rehabilitation
Nurses
Interviews

Bibliographical note

This is the peer reviewed version of the following article: Phillips, C, Schulkind, J, O’Sullivan, M, et al. Improving access to care for people who inject drugs: Qualitative evaluation of project ITTREAT—An integrated community hepatitis C service. J Viral Hepat. 2019; 00: 1– 12., which has been published in final form at https://onlinelibrary.wiley.com/doi/full/10.1111/jvh.13214. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions.

Keywords

  • Hepatitis C
  • substance misuse
  • service delivery
  • barriers
  • facilitators
  • community HCV service
  • hepatitis C virus
  • staff/client experience

Cite this

Phillips, Claire ; Schulkind, Jasmine ; O'Sullvan, Margaret ; Edelman, Natalie ; Smith, Helen ; Verma, Sumita ; Jones, Christina. / Improving access to care for people who inject drugs : Qualitative evaluation of project ITTREAT—An integrated community hepatitis C service. In: Journal of Viral Hepatitis. 2019.
@article{af2353f1695e4a12a6f24a4a63171666,
title = "Improving access to care for people who inject drugs: Qualitative evaluation of project ITTREAT—An integrated community hepatitis C service",
abstract = "Achieving hepatitis C virus (HCV) elimination by 2030 requires an increased linkage to care for people who inject drugs (PWID). Project ITTREAT was established to mitigate barriers to HCV care by providing an integrated service within a local drug and alcohol treatment centre. This study aimed to explore the experiences of clients and staff involved in Project ITTREAT and assess the facilitators and barriers to a community‐based HCV service. Between October 2014 and April 2016, drug and alcohol treatment attendees were interviewed using one‐to‐one semi‐structured interviews. Drug and alcohol treatment staff took part in focus groups. All data were recorded, transcribed verbatim and analysed using thematic content analysis. Fifteen drug and alcohol treatment attendees with current/previous HCV infection were interviewed, and 15 staff members contributed across two focus groups. Drug and alcohol treatment staff and attendees reported that Project ITTREAT facilitated access to HCV care by mitigating previous negative hospital‐based experiences. Other key facilitators were positive narratives around HCV care, and drug and alcohol treatment attendees being well engaged in their drug/alcohol recovery. Barriers included a lack of stability in drug and alcohol treatment attendees, negative discourse around testing/ treatment and stigma associated with attending the drug and alcohol treatment to access HCV treatment in some who had successfully achieved drug rehabilitation. Our findings indicate the positive impact of an integrated and personalized community‐based service delivered by a dedicated hepatitis nurse. This played a crucial role in reducing barriers to HCV care for PWID. Our work also highlights areas for future investment including non–DAT‐based community services and increasing awareness of new treatments amongst this cohort.",
keywords = "Hepatitis C, substance misuse, service delivery, barriers, facilitators, community HCV service, hepatitis C virus, staff/client experience",
author = "Claire Phillips and Jasmine Schulkind and Margaret O'Sullvan and Natalie Edelman and Helen Smith and Sumita Verma and Christina Jones",
note = "This is the peer reviewed version of the following article: Phillips, C, Schulkind, J, O’Sullivan, M, et al. Improving access to care for people who inject drugs: Qualitative evaluation of project ITTREAT—An integrated community hepatitis C service. J Viral Hepat. 2019; 00: 1– 12., which has been published in final form at https://onlinelibrary.wiley.com/doi/full/10.1111/jvh.13214. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions.",
year = "2019",
month = "9",
day = "30",
doi = "10.1111/jvh.13214",
language = "English",

}

Improving access to care for people who inject drugs : Qualitative evaluation of project ITTREAT—An integrated community hepatitis C service. / Phillips, Claire; Schulkind, Jasmine; O'Sullvan, Margaret; Edelman, Natalie; Smith, Helen; Verma, Sumita ; Jones, Christina.

In: Journal of Viral Hepatitis, 30.09.2019.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Improving access to care for people who inject drugs

T2 - Qualitative evaluation of project ITTREAT—An integrated community hepatitis C service

AU - Phillips, Claire

AU - Schulkind, Jasmine

AU - O'Sullvan, Margaret

AU - Edelman, Natalie

AU - Smith, Helen

AU - Verma, Sumita

AU - Jones, Christina

N1 - This is the peer reviewed version of the following article: Phillips, C, Schulkind, J, O’Sullivan, M, et al. Improving access to care for people who inject drugs: Qualitative evaluation of project ITTREAT—An integrated community hepatitis C service. J Viral Hepat. 2019; 00: 1– 12., which has been published in final form at https://onlinelibrary.wiley.com/doi/full/10.1111/jvh.13214. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions.

PY - 2019/9/30

Y1 - 2019/9/30

N2 - Achieving hepatitis C virus (HCV) elimination by 2030 requires an increased linkage to care for people who inject drugs (PWID). Project ITTREAT was established to mitigate barriers to HCV care by providing an integrated service within a local drug and alcohol treatment centre. This study aimed to explore the experiences of clients and staff involved in Project ITTREAT and assess the facilitators and barriers to a community‐based HCV service. Between October 2014 and April 2016, drug and alcohol treatment attendees were interviewed using one‐to‐one semi‐structured interviews. Drug and alcohol treatment staff took part in focus groups. All data were recorded, transcribed verbatim and analysed using thematic content analysis. Fifteen drug and alcohol treatment attendees with current/previous HCV infection were interviewed, and 15 staff members contributed across two focus groups. Drug and alcohol treatment staff and attendees reported that Project ITTREAT facilitated access to HCV care by mitigating previous negative hospital‐based experiences. Other key facilitators were positive narratives around HCV care, and drug and alcohol treatment attendees being well engaged in their drug/alcohol recovery. Barriers included a lack of stability in drug and alcohol treatment attendees, negative discourse around testing/ treatment and stigma associated with attending the drug and alcohol treatment to access HCV treatment in some who had successfully achieved drug rehabilitation. Our findings indicate the positive impact of an integrated and personalized community‐based service delivered by a dedicated hepatitis nurse. This played a crucial role in reducing barriers to HCV care for PWID. Our work also highlights areas for future investment including non–DAT‐based community services and increasing awareness of new treatments amongst this cohort.

AB - Achieving hepatitis C virus (HCV) elimination by 2030 requires an increased linkage to care for people who inject drugs (PWID). Project ITTREAT was established to mitigate barriers to HCV care by providing an integrated service within a local drug and alcohol treatment centre. This study aimed to explore the experiences of clients and staff involved in Project ITTREAT and assess the facilitators and barriers to a community‐based HCV service. Between October 2014 and April 2016, drug and alcohol treatment attendees were interviewed using one‐to‐one semi‐structured interviews. Drug and alcohol treatment staff took part in focus groups. All data were recorded, transcribed verbatim and analysed using thematic content analysis. Fifteen drug and alcohol treatment attendees with current/previous HCV infection were interviewed, and 15 staff members contributed across two focus groups. Drug and alcohol treatment staff and attendees reported that Project ITTREAT facilitated access to HCV care by mitigating previous negative hospital‐based experiences. Other key facilitators were positive narratives around HCV care, and drug and alcohol treatment attendees being well engaged in their drug/alcohol recovery. Barriers included a lack of stability in drug and alcohol treatment attendees, negative discourse around testing/ treatment and stigma associated with attending the drug and alcohol treatment to access HCV treatment in some who had successfully achieved drug rehabilitation. Our findings indicate the positive impact of an integrated and personalized community‐based service delivered by a dedicated hepatitis nurse. This played a crucial role in reducing barriers to HCV care for PWID. Our work also highlights areas for future investment including non–DAT‐based community services and increasing awareness of new treatments amongst this cohort.

KW - Hepatitis C

KW - substance misuse

KW - service delivery

KW - barriers

KW - facilitators

KW - community HCV service

KW - hepatitis C virus

KW - staff/client experience

UR - http://www.scopus.com/inward/record.url?scp=85074091532&partnerID=8YFLogxK

U2 - 10.1111/jvh.13214

DO - 10.1111/jvh.13214

M3 - Article

ER -